Table 3.

The prevalence of HT and characteristics of subjects stratified according to 25(OH)D classification.

	Sufficiency (n = 161)	Insufficiency (n = 1,298)	Deficiency (n = 3,803)	P- value
Male gender, %	112 (69.6%)	899 (69.3%)b	2152 (56.6%)c	<0.001
Age, years	52.45 ± 8.83	50.63 ± 8.79b	48.23 ± 9.06c	<0.001*
BMI, kg/m2	24.27 ± 3.10	24.72 ± 3.06b	24.19 ± 3.37	<0.001*
WC, cm	85.34 ± 8.97	86.67 ± 9.61b	84.37 ± 10.91	<0.001*
BLOOD PRESSURE
SBP, mmHg	124.75 ± 13.16	123.53 ± 15.58b	120.22 ± 15.92c	<0.001*
DBP, mmHg	73.94 ± 10.14	73.52 ± 10.91b	71.58 ± 11.22c	<0.001*
FBG, mmol/L	5.52 ± 1.10	5.59 ± 1.45b	5.40 ± 1.17	<0.001*
TG, mg/dl	1.90 ± 1.46	2.01 ± 1.80b	1.79 ± 1.42	<0.001*
TC, mg/dl	4.99 ± 1.05	4.87 ± 0.94b	4.69 ± 0.91c	<0.001*
HDL-C, mg/dl	1.24 ± 0.34	1.15 ± 0.28b	1.17 ± 0.29c	<0.001*
LDL-C, mg/dl	2.65 ± 0.82	2.61 ± 0.71	2.57 ± 0.72	0.172
ALT, IU/L	24.42 ± 14.55	26.20 ± 21.67	25.97 ± 22.89	0.635
AST, IU/L	20.43 ± 6.93	20.66 ± 11.53	20.13 ± 11.03	0.324
UA, μmol/L	368.79 ± 87.17	376.16 ± 88.22b	355.69 ± 90.35	<0.001*
TSH, mIU/L	1.72 ± 1.06	1.71 ± 1.06b	1.81 ± 1.17	0.024*
FT3, pg/ml	2.82 ± 0.60	2.80 ± 0.36b	2.75 ± 0.36c	<0.001*
FT4, ng/dl	2.21 ± 1.05a	1.86 ± 0.91b	1.40 ± 0.73c	<0.001*
Tg-Ab, IU/ml	16.42 ± 101.36	11.13 ± 53.11	16.15 ± 70.76	0.069
TPO-Ab, IU/ml	20.13 ± 106.75	16.17 ± 81.40	17.85 ± 88.50	0.776
HT (yes)	12 (7.5%)	100 (7.7%)	354 (9.3%)	0.186†

Tg-Ab, thyroglobulin antibody; TPO-Ab, thyroid peroxidase antibody.

^*One-way ANOVA;

^†chi-square test.

^aSignificant difference between insufficiency group and sufficiency group;

^bsignificant difference between deficiency group and sufficiency group;

^csignificant difference between insufficiency group and deficiency group.